Medifast (MED) Shares Outstanding (Weighted Average) (2010 - 2026)

Medifast has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $11.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 0.53% year-over-year to $11.0 million; the trailing twelve-month figure through Mar 2026 stood at $11.0 million (up 0.53% YoY), and the FY2025 full-year result was $11.0 million, changed 0.47% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $11.0 million, roughly flat from $11.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $11.6 million in Q1 2022, with the low at $10.9 million in Q1 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $11.0 million across 5 years, with a median of $10.9 million in 2025.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) retreated 6.23% — and 2024, when it gained 0.56%.
• Medifast's Shares Outstanding (Weighted Average) stood at $11.2 million in 2022, then declined by 2.78% to $10.9 million in 2023, then advanced by 0.42% to $10.9 million in 2024, then climbed by 0.47% to $11.0 million in 2025, then increased by 0.23% to $11.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $11.0 million (Q1 2026), $11.0 million (Q4 2025), and $11.0 million (Q3 2025), per Business Quant data.